Oghenekome Gbinigie

University of Oxford — United Kingdom

Medicine · Health Sciences

21h-index2.1kcitations38works17.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

COVID-19 Clinical Research Studies(13), SARS-CoV-2 and COVID-19 Research(7), Urinary Tract Infections Management(6), Long-Term Effects of COVID-19(6), Pelvic floor disorders treatments(4)

Publications37 total

Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
Journal of Infection·2024· 21 citedOpen Access
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients
Nature Communications·2024· 38 citedOpen Access
Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19: an economic evaluation of the PANORAMIC trial
British Journal of General Practice·2024· 9 citedOpen Access
Molnupiravir Treatment for COVID-19 in People at Higher Risk in the Community: Outcomes from the PANORAMIC Randomised Controlled Trial at Three and Six Months
SSRN Electronic Journal·2024· 1 citedOpen Access
Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease
BMJ Open·2023· 21 citedOpen Access
Inhaled Budesonide for COVID-19 in People at Higher Risk of Complications in the Community: The UK National Community Randomi
2023· 1 citedOpen Access
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
The Lancet·2022· 391 citedOpen Access
Enhancing opportunistic recruitment and retention in primary care trials: lessons learned from a qualitative study embedded in the Cranberry for Urinary Tract Infection (CUTI) feasibility trial
BMC Primary Care·2022Open Access
Molnupiravir Plus Usual Care Versus Usual Care Alone as Early Treatment for Adults with COVID-19 at Increased Risk of Adverse Outcomes (PANORAMIC): Preliminary Analysis from the United Kingdom Randomised, Controlled Open-Label, Platform Adaptive Trial
SSRN Electronic Journal·2022· 50 citedOpen Access
Colchicine for COVID-19 in adults in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial
2021· 11 citedOpen Access
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
The Lancet·2021· 302 citedOpen Access
Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
The Lancet Respiratory Medicine·2021· 77 citedOpen Access
PRINCIPLE trial demonstrates scope for in-pandemic improvement in primary care antibiotic stewardship: a retrospective sentinel network cohort study
BJGP Open·2021· 24 citedOpen Access
Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE): protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk
BMJ Open·2021· 27 citedOpen Access
Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial
2021· 27 citedOpen Access
Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
The Lancet·2021· 306 citedOpen Access
PRINCIPLE trial demonstrates scope for in-pandemic improvement in primary care antibiotic stewardship
2021· 10 citedOpen Access
Does cranberry extract reduce antibiotic use for symptoms of acute uncomplicated urinary tract infections (CUTI)? A feasibility randomised trial
BMJ Open·2021· 18 citedOpen Access
Cranberry extract for symptoms of acute, uncomplicated urinary tract infection
Oxford University Research Archive (ORA) (University of Oxford)·2021Open Access
Cranberry Extract for Symptoms of Acute, Uncomplicated Urinary Tract Infection: A Systematic Review
Antibiotics·2020· 29 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Christopher Butler(23), Oliver van Hecke(17), Richard Hobbs(16), Jienchi Dorward(16), Gail Hayward(15), Ly‐Mee Yu(14), Benjamin R. Saville(13), Nicholas Thomas(13), Philip Evans(13), Emma Ogburn(12), Victoria Harris(12), Duncan Richards(10), Monique Andersson(10), Simon de Lusignan(10), Michelle A. Detry(9), Christina Saunders(9), Mark Fitzgerald(9), Nicholas Berry(9), Mihir Patel(8), Julie Allen(8)